Exact Mass: 509.3352352
Exact Mass Matches: 509.3352352
Found 67 metabolites which its exact mass value is equals to given mass value 509.3352352
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Narbomycin
A macrolide antibiotic that is narbonolide having a 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residue attached at position 6. It is biosynthesised by Streptomyces venezuelae.
Cholylthreonine
Cholylthreonine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylthreonine consists of the bile acid cholic acid conjugated to the amino acid Threonine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylthreonine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylthreonine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
His Ile Ile Lys
C24H43N7O5 (509.33255080000004)
His Ile Lys Ile
C24H43N7O5 (509.33255080000004)
His Ile Lys Leu
C24H43N7O5 (509.33255080000004)
His Ile Leu Lys
C24H43N7O5 (509.33255080000004)
His Lys Ile Ile
C24H43N7O5 (509.33255080000004)
His Lys Ile Leu
C24H43N7O5 (509.33255080000004)
His Lys Leu Ile
C24H43N7O5 (509.33255080000004)
His Lys Leu Leu
C24H43N7O5 (509.33255080000004)
His Leu Ile Lys
C24H43N7O5 (509.33255080000004)
His Leu Lys Ile
C24H43N7O5 (509.33255080000004)
His Leu Lys Leu
C24H43N7O5 (509.33255080000004)
His Leu Leu Lys
C24H43N7O5 (509.33255080000004)
Ile His Ile Lys
C24H43N7O5 (509.33255080000004)
Ile His Lys Ile
C24H43N7O5 (509.33255080000004)
Ile His Lys Leu
C24H43N7O5 (509.33255080000004)
Ile His Leu Lys
C24H43N7O5 (509.33255080000004)
Ile Ile His Lys
C24H43N7O5 (509.33255080000004)
Ile Ile Lys His
C24H43N7O5 (509.33255080000004)
Ile Lys His Ile
C24H43N7O5 (509.33255080000004)
Ile Lys His Leu
C24H43N7O5 (509.33255080000004)
Ile Lys Ile His
C24H43N7O5 (509.33255080000004)
Ile Lys Leu His
C24H43N7O5 (509.33255080000004)
Ile Leu His Lys
C24H43N7O5 (509.33255080000004)
Ile Leu Lys His
C24H43N7O5 (509.33255080000004)
Lys His Ile Ile
C24H43N7O5 (509.33255080000004)
Lys His Ile Leu
C24H43N7O5 (509.33255080000004)
Lys His Leu Ile
C24H43N7O5 (509.33255080000004)
Lys His Leu Leu
C24H43N7O5 (509.33255080000004)
Lys Ile His Ile
C24H43N7O5 (509.33255080000004)
Lys Ile His Leu
C24H43N7O5 (509.33255080000004)
Lys Ile Ile His
C24H43N7O5 (509.33255080000004)
Lys Ile Leu His
C24H43N7O5 (509.33255080000004)
Lys Leu His Ile
C24H43N7O5 (509.33255080000004)
Lys Leu His Leu
C24H43N7O5 (509.33255080000004)
Lys Leu Ile His
C24H43N7O5 (509.33255080000004)
Lys Leu Leu His
C24H43N7O5 (509.33255080000004)
Leu His Ile Lys
C24H43N7O5 (509.33255080000004)
Leu His Lys Ile
C24H43N7O5 (509.33255080000004)
Leu His Lys Leu
C24H43N7O5 (509.33255080000004)
Leu His Leu Lys
C24H43N7O5 (509.33255080000004)
Leu Ile His Lys
C24H43N7O5 (509.33255080000004)
Leu Ile Lys His
C24H43N7O5 (509.33255080000004)
Leu Lys His Ile
C24H43N7O5 (509.33255080000004)
Leu Lys His Leu
C24H43N7O5 (509.33255080000004)
Leu Lys Ile His
C24H43N7O5 (509.33255080000004)
Leu Lys Leu His
C24H43N7O5 (509.33255080000004)
Leu Leu His Lys
C24H43N7O5 (509.33255080000004)
Leu Leu Lys His
C24H43N7O5 (509.33255080000004)
N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C30H43N3O4 (509.32533980000005)
N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C30H43N3O4 (509.32533980000005)
4-[3-acetyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
(3r,6r)-3-({7-[(2s)-2-hydroxy-3-methoxy-3-methylbutyl]-5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol
C30H43N3O4 (509.32533980000005)
3-{[7-(2-hydroxy-3-methoxy-3-methylbutyl)-5-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol
C30H43N3O4 (509.32533980000005)